MedPath

Effect of Stress-management and Biofeedback on Craving in Smoking Abstinence: A Pilot Study

Phase 2
Completed
Conditions
Smoking Cessation
Interventions
Behavioral: breathing technique
Behavioral: behavioral strategies
Registration Number
NCT01080092
Lead Sponsor
University Hospital, Ghent
Brief Summary

Craving is one of the most prominent reasons for relapse after smoking cessation. Mainly pharmacological aids (NRT, bupropion, varenicline) try to counter this condition. This project aims to evaluate the effect of stress-management and a short breathing technique, reinforced by means of visualisation , on the experience of craving in smokers who are prepared to stay abstinent for at least 3 hours before the start of the intervention. It is expected that this strategy can provide supplementary gains in craving control.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • smokers (at least 10 cigarettes/day);
  • 18 years of age or older;
  • prepared to stay abstinent for 3 hours before the start of the session;
  • not prepared to stop smoking;
  • Dutch speaking.
Exclusion Criteria
  • acute health related problems;
  • psychiatric co-morbidities;
  • quit attempts in the past 3 months;
  • participation in other clinical trials.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
breathing technique groupbreathing techniquetechnique as a stress management technique, reinforced by biofeedback
no breathing techniquebehavioral strategiesthe control group reads a paper on the properties and components of tobacco and on behavioural strategies to cope with craving
Primary Outcome Measures
NameTimeMethod
Craving at the end of each of two (learning) sessions;1 day

Measurement by means of participant's estimation of feelings of smoking urge and smoking craving (by means of the Minnesota Nicotine Withdrawal Scale) before and immeadiately after each of two intervention sessions)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Ghent

🇧🇪

Ghent, Belgium

© Copyright 2025. All Rights Reserved by MedPath